-
Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Amino acid series |Fmoc-3-(2-Naphthyl)-L-alanine |CAS:112883-43-9 |C28H23NO4
-
Fmoc-Trp(Boc)-OH 143824-78-6
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Fmoc-Trp(Boc)-OH |CAS:143824-78-6 |C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Amino acid series |Fmoc-L-Leucine |CAS:35661-60-0 |C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Amino acid series |Fmoc-D-leucine |CAS:114360-54-2 |C21H23NO4
-
![N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3](https://www.yisunbio.com/uploads/281.jpg)
N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine |CAS:1202003-49-3 |C27H34N2O6
-
![O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7](https://www.yisunbio.com/uploads/29-300x115.jpg)
O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine |CAS:1013883-02-7 |C31H34N2O7
-
Hippuric acid 495-69-2
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Hippuric acid |CAS:495-69-2 |C9H9NO3
-
Valsartan 137862-53-4
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Vailaau Fa'asu'esu'e |Vailaau Matagofie |Alamanuia vailaau vavalo |Cardiovascular |Togafitiga toto maualuga |Valsartan Intermediates |Valsartan |CAS:137862-53-4 |C24H29N5O3
-
L-Valine methyl ester hydrochloride 6306-52-1
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Vailaau Fa'asu'esu'e |Vailaau Matagofie |Alamanuia vailaau vavalo |Cardiovascular |Valsartan Intermediates |L-Valine methyl ester hydrochloride |CAS:6306-52-1 |C6H13NO2.HCl
-
![N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Vailaau Fa'asu'esu'e |Vailaau Matagofie |Alamanuia vailaau vavalo |Cardiovascular |Togafitiga toto maualuga |Valsartan Intermediates |N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride |CAS:482577-59-3 |C20H22N2O2.HCl
-
Valsartan methyl ester 137863-17-3
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Vailaau Fa'asu'esu'e |Vailaau Matagofie |Alamanuia vailaau vavalo |Cardiovascular |Togafitiga toto maualuga |Valsartan Intermediates |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine methyl ester |CAS:137863-17-3 |C25H31N5O3
-
(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol 126534-31-4
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Fa'ama'i pipisi |Dermatologic |Luliconazole Intermediates |(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemetano |CAS:126534-31-4 |C8H7Cl3O